Impulse News

First Implant in the Kingdom of Saudi Arabia – Continued Global Growth for Impulse Dynamics’ Optimizer IVs Device.

Stuttgart, Germany – August 23rd, 2015 – Impulse Dynamics announced today (23 August, 2015) the first implantation of its Optimizer IVs device in the Kingdom of Saudi Arabia, at the King Faisal Specialist Hospital & Research Centre (KFSH&RC) in Riyadh. The implantation was performed by Dr. Bandar Al Ghamdi. The CCM team at KFSH&RC includes Dr. […]

Mehr dazu

Impulse Dynamics announced the first implantation of the Optimizer IVs device in Poland

Stuttgart, Germany – August 13th, 2015 – Impulse Dynamics announced today (13 August, 2015) the first implantation of its Optimizer IVs device in Poland, at the University Hospital  – Central Veterans‘ Hospital in Lodz.  The implantation was performed by Dr. Krzysztof Kaczmarek and Professor Pawe? Ptaszy?ski.  The Department of Electrocardiology in Lodz managed by Professor […]

Mehr dazu

Continued Expansion for Impulse Dynamics Optimizer IVs device – First implantations in Switzerland

Stuttgart, Germany – August 6th, 2015 – Impulse Dynamics, announced today the first implantation of its Optimizer IVs device in Switzerland, continuing the global expansion of its innovative technology. The Optimizer IVs is a minimally invasive implantable device for treatment of Chronic Heart Failure (CHF). The device is based on novel Cardiac Contractility Modulation (CCM) […]

Mehr dazu

Impulse Dynamics announces the first implantation of the Optimizer IVs device in a patient with a concomitant S-ICD in the United States

Orangeburg, New York – July 28, 2015 – Impulse Dynamics (USA), Inc. announced that Cardiac electrophysiologist, Andrew Kaplan, M.D., FACC, FHRS became the first physician in the United States to implant the Optimizer™ IVs investigational device as part of the FIX-HF-5C FDA IDE protocol in a heart failure patient with a previously implanted subcutaneous (under […]

Mehr dazu

Impulse Dynamics presented encouraging outcomes during EHRA EUROPACE Cardiostim, 21 – 24.06.2015

Stuttgart, Germany – 24th June 2015 – the unique advantages of the CCM therapy and its encouraging outcomes were presented during EHRA EUROPACE Cardiostim to professionals from around the globe. The CCM therapy has demonstrated its safety and efficacy through a number of randomized clinical trials. The results were displayed at two poster sessions and […]

Mehr dazu